Hydrus
Device
Ivantis, Inc
Total Payments
$1.3M
Transactions
3,797
Doctors
1,762
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $550,629 | 2,032 | 1,135 |
| 2019 | $776,412 | 1,765 | 903 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $590,551 | 173 | 44.5% |
| Consulting Fee | $527,056 | 341 | 39.7% |
| Food and Beverage | $189,314 | 3,244 | 14.3% |
| Travel and Lodging | $13,437 | 30 | 1.0% |
| Honoraria | $6,000 | 2 | 0.5% |
| Gift | $576.03 | 3 | 0.0% |
| Entertainment | $107.56 | 4 | 0.0% |
Payments by Type
General
$736,491
3,624 transactions
Research
$590,551
173 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Safety & Effectiveness Study of the Hydrus Microstent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery (HORIZON) | Ivantis, Inc | $322,222 | 2 |
| Hydrus Microstent for Refractory Open-Angle Glaucoma: a Prospective| Multicenter Clinical Trial (SUMMIT) | Ivantis, Inc | $126,942 | 0 |
| Hydrus(R) Microstent New Enrollment Post-Approval Study | Ivantis, Inc | $54,899 | 1 |
| Hydrus Microstent for Refractory Open-Angle Glaucoma: a Prospective| Multicenter Clinical Trial | Ivantis, Inc | $32,148 | 2 |
| Characterization of Efficacy and Safety of the Hydrus Microstent for Glaucoma Management: Analysis of the SPECTRUM Registry Database | Ivantis, Inc | $23,000 | 0 |
| Hydrus Microstent for Refractory Open-Angle Glaucoma: a Prospective Multicenter Clinical Trial (SUMMIT) | Ivantis, Inc | $22,290 | 1 |
| Hydrus Post-Market Review | Ivantis, Inc | $8,500 | 0 |
Top Doctors Receiving Payments for Hydrus — Page 71
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Ophthalmology | Greensboro, NC | $11.37 | 1 |
| , MD | Ophthalmology | Greensboro, NC | $11.37 | 1 |
| , M.D | Ophthalmology | Los Angeles, CA | $11.29 | 1 |
| Julia Polat | Ophthalmology | Pittsburgh, PA | $11.20 | 1 |
| Margaret Pollard | Ophthalmology | Pittsburgh, PA | $11.20 | 1 |
| John Swogger | Ophthalmology | Columbus, OH | $11.20 | 1 |
| , M.D | Family Medicine | South Richmond Hill, NY | $11.19 | 1 |
| , O.D | Optometrist | Smithfield, NC | $11.14 | 1 |
| , M.D | Ophthalmology | Atlanta, GA | $10.97 | 1 |
| , OD | Optometrist | North Little Rock, AR | $10.93 | 1 |
| , M.D | Ophthalmology | Greensboro, NC | $10.81 | 1 |
| , DO | Ophthalmology | Fort Collins, CO | $10.58 | 1 |
| , O.D | Optometrist | Augusta, GA | $10.54 | 1 |
Ad
Manufacturing Companies
- Ivantis, Inc $1.3M
- THE CAMERON-EHLEN GROUP, INC. $3,846
Product Information
- Type Device
- Total Payments $1.3M
- Total Doctors 1,762
- Transactions 3,797
About Hydrus
Hydrus is a device associated with $1.3M in payments to 1,762 healthcare providers, recorded across 3,797 transactions in the CMS Open Payments database. The primary manufacturer is Ivantis, Inc.
Payment data is available from 2019 to 2020. In 2020, $550,629 was paid across 2,032 transactions to 1,135 doctors.
The most common payment nature for Hydrus is "Unspecified" ($590,551, 44.5% of total).
Hydrus is associated with 7 research studies, including "Safety & Effectiveness Study of the Hydrus Microstent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery (HORIZON)" ($322,222).